As the SP in BC is identified by functional expression of multidrug-resistant proteins, in particular BCRP, our findings may present a new rationale for the poor response of HER2-positive and hormone-resistant BC to conventional chemotherapeutics. This evidence concerns the gene ERBB2 and breast cancer.